Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2026-02-23
Product name
mRNA Guanylyltransferase
Emergency telephone
+49(0)621-759-2203, +49(0)6131-19240, +496217592890
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
Section 2
SECTION 2: Hazards identification
GHS Classification Not a hazardous substance or mixture
2.2 Label elements
No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required.
2.1 Classification of the substance or mixture
Not a hazardous substance or mixture. GHS label elements No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Substance / Mixture : Mixture Components Chemical name CAS-No. Concentration (% w/w) Glycerol 56-81-5 >= 30 - < 60 mRNA Guanylyltransferase 56941-23-2 < 10 SECTION 4. FIRST AID MEASURES General advice : Do not leave the victim unattended. mRNA Guanylyltransferase 3 If inhaled : If unconscious, place in recovery position and seek medical advice. If symptoms persist, call a physician. In case of skin contact : Wash off with soap and water. In case of eye contact : Remove contact lenses. Protect unharmed eye. If eye irritation persists, consult a specialist. If swallowed : Keep respiratory tract clear. Do not give milk or alcoholic beverages. Never give anything by mouth to an unconscious person. If symptoms persist, call a physician. Most important symptoms : None known. and effects, both acute and delayed Notes to physician : Treat symptomatically. SECTION 5. FIREFIGHTING MEASURES Suitable extinguishing media : Use extinguishing measures that are appropriate to local circumstances and the surrounding environment. Unsuitable extinguishing : High volume water jet media Specific hazards during
